tiprankstipranks
Trending News
More News >
Century Sage Scientific Holdings Ltd (HK:1450)
:1450
Hong Kong Market
Advertisement

Century Sage Scientific Holdings Ltd (1450) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Century Sage Scientific Holdings Ltd has a market cap or net worth of HK$1.35B. The enterprise value is HK$1.37B.
Market CapHK$1.35B
Enterprise ValueHK$1.37B

Share Statistics

Century Sage Scientific Holdings Ltd has 1,387,203,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,387,203,100
Owned by Insiders
Owned by Institutions

Financial Efficiency

Century Sage Scientific Holdings Ltd’s return on equity (ROE) is 0.20 and return on invested capital (ROIC) is 11.36%.
Return on Equity (ROE)0.20
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)11.36%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee1.08M
Profits Per Employee87.29K
Employee Count1,163
Asset Turnover1.35
Inventory Turnover2.59

Valuation Ratios

The current PE Ratio of Century Sage Scientific Holdings Ltd is 23.2. Century Sage Scientific Holdings Ltd’s PEG ratio is -0.57.
PE Ratio23.2
PS Ratio1.12
PB Ratio3.34
Price to Fair Value3.34
Price to FCF-30.59
Price to Operating Cash Flow13.32
PEG Ratio-0.57

Income Statement

In the last 12 months, Century Sage Scientific Holdings Ltd had revenue of 1.25B and earned 81.71M in profits. Earnings per share was 0.06.
Revenue1.25B
Gross Profit599.30M
Operating Income106.90M
Pretax Income101.52M
Net Income81.71M
EBITDA119.87M
Earnings Per Share (EPS)0.06

Cash Flow

In the last 12 months, operating cash flow was 90.66M and capital expenditures -9.93M, giving a free cash flow of 80.73M billion.
Operating Cash Flow90.66M
Free Cash Flow80.73M
Free Cash Flow per Share0.06

Dividends & Yields

Century Sage Scientific Holdings Ltd pays an annual dividend of HK$0.006, resulting in a dividend yield of ―
Dividend Per ShareHK$0.006
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.36
52-Week Price Change-11.82%
50-Day Moving Average0.99
200-Day Moving Average0.97
Relative Strength Index (RSI)48.68
Average Volume (3m)1.35M

Important Dates

Century Sage Scientific Holdings Ltd upcoming earnings date is Mar 31, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend DateJun 16, 2017

Financial Position

Century Sage Scientific Holdings Ltd as a current ratio of 1.50, with Debt / Equity ratio of 10.48%
Current Ratio1.50
Quick Ratio0.96
Debt to Market Cap0.16
Net Debt to EBITDA1.16
Interest Coverage Ratio8.30

Taxes

In the past 12 months, Century Sage Scientific Holdings Ltd has paid 29.29M in taxes.
Income Tax29.29M
Effective Tax Rate0.29

Enterprise Valuation

Century Sage Scientific Holdings Ltd EV to EBITDA ratio is 12.82, with an EV/FCF ratio of -33.64.
EV to Sales1.23
EV to EBITDA12.82
EV to Free Cash Flow-33.64
EV to Operating Cash Flow-55.73

Balance Sheet

Century Sage Scientific Holdings Ltd has HK$235.59M in cash and marketable securities with HK$51.70M in debt, giving a net cash position of HK$183.90M billion.
Cash & Marketable SecuritiesHK$235.59M
Total DebtHK$51.70M
Net CashHK$183.90M
Net Cash Per ShareHK$0.13
Tangible Book Value Per ShareHK$0.24

Margins

Gross margin is 44.05%, with operating margin of 8.55%, and net profit margin of 6.53%.
Gross Margin44.05%
Operating Margin8.55%
Pretax Margin8.12%
Net Profit Margin6.53%
EBITDA Margin9.59%
EBIT Margin8.71%

Analyst Forecast

The average price target for Century Sage Scientific Holdings Ltd is HK$1.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$1.00
Price Target Upside5.26% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-1.52%
EPS Growth Forecast-67.16%

Scores

Smart Score4
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis